ダウンロード数: 725
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
32_1617.pdf | 3.73 MB | Adobe PDF | 見る/開く |
タイトル: | 膀胱癌症例に対する膀胱粘膜多部位生検に関する研究 第1編: 膀胱粘膜多部位生検における組織学的所見の検討 |
その他のタイトル: | Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining |
著者: | 井川, 幹夫 |
著者名の別形: | IGAWA, Mikio |
キーワード: | Bladder cancer Multiple mucosal biopsy In vivo methylene blue staining |
発行日: | Nov-1986 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 32 |
号: | 11 |
開始ページ: | 1617 |
終了ページ: | 1631 |
抄録: | 1980年3月から1984年7月までに経験した膀胱癌111例を対象として, 膀胱粘膜多部位生検法を165回施行した.955検体における組織学的所見の内訳は, 移行上皮癌4.7%, 上皮内癌の微小浸潤3.1%, 上皮内癌5.8%, 上皮異形成2.8%などであった.組織学的異常は再発例に21.1%と多く, 膀胱鏡で異常が観察された粘膜の65.5%に組織学的にも異常が見られた.可視的腫瘍の多発例に組織学的異常が多く認められ, 生検部位別には組織学的異常の頻度は腫瘍近接部位が26.9%と有意に高く, 主腫瘍の組織学的異型度と生検粘膜の組織学的所見との関連を見ると, G3が36.0%で組織学的異型度の上昇とともに高くなった.尿細胞診の陽性率は主腫瘍の組織学的異型度がG3で83%を占め, GIの尿細胞診陽性例はすべて粘膜生検で上皮内癌が認められた.内視鏡で正常な粘膜の生検を行い, 組織学的異常が認められる頻度は, メチレンブルー主染色陽性群で15.9%と有意に高かった Between March, 1980 and July, 1984, 165 multiple mucosal biopsies were performed in 111 patients with bladder cancer. Of these 165 multiple mucosal biopsies, 87 were performed in new cases and 78 in recurrent cases: 147 were performed under in vivo staining with intravesical methylene blue. Before endoscopic tumor resection, biopsies were taken with a flexible cup biopsy forceps from non-tumorous urothelium lateral to the ureteral orifices, in the midline posteriorly, from both lateral wall and bladder neck, adjacent to the tumor and from the tumor itself. Histological abnormalities in this paper indicate transitional cell carcinoma, microinvasion of carcinoma in situ, carcinoma in situ, dysplasia and hyperplasia. In the total 955 biopsy specimens, transitional cell carcinoma was found in 45 (4.7%), microinvasion of carcinoma in situ in 30 (3.1%), carcinoma in situ in 55 (5.8%), dysplasia in 27 (2.8%), hyperplasia in 141 (1.5%), squamous metaplasia in 4 (0.4%), proliferative cystitis in 58 (6.1%), inflammation in 230 (24.1%) and normal epithelium in 492 (51.5%). The frequency of histological abnormalities in biopsied specimens was 14.8% in new cases, 21.1% in recurrent cases, the difference being statistically significant (P less than 0.01). Transitional cell carcinoma and dysplasia were more common in mucosal biopsies of recurrent cases than those of new cases (P less than 0.001, P less than 0.05). The frequency of histological abnormalities was 11.5% in 836 biopsy specimens from cystoscopically normal-looking mucosa, while 65.5% in 119 biopsy specimens from grossly abnormal mucosa, the difference being statistically significant (P less than 0.001). Of histological abnormalities, transitional cell carcinoma, microinvasion of carcinoma in situ and carcinoma in situ were more common in biopsy specimens from grossly abnormal mucosa than those from normal-looking mucosa (P less than 0.001). The frequency of histological abnormalities in mucosal biopsy was 11.4% in patients who exhibited a single tumor, and 26.7% in those with multiple tumors, the difference being significant (P less than 0.005). Biopsies of mucosa adjacent to a visible tumor were abnormal most frequently (26.9%), while those taken lateral to the ureteral orifices, from the midline posteriorly and from both lateral wall revealed a slightly lower rate of abnormal findings. The frequency of histological abnormalities in mucosal biopsy was 7.7% in patients with G1 tumor, 15.8% in those with G2 tumor and 36.0% in those with G3 tumor. The histological abnormalities increased with the increase in the grade of main tumor; this correlation was statistically significant (P less than 0.001).(ABSTRACT TRUNCATED AT 400 WORDS) |
URI: | http://hdl.handle.net/2433/118962 |
PubMed ID: | 2435127 |
出現コレクション: | Vol.32 No.11 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。